Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 236

1.

West Nile alternative open reading frame (N-NS4B/WARF4) is produced in infected West Nile Virus (WNV) cells and induces humoral response in WNV infected individuals.

Faggioni G, Pomponi A, De Santis R, Masuelli L, Ciammaruconi A, Monaco F, Di Gennaro A, Marzocchella L, Sambri V, Lelli R, Rezza G, Bei R, Lista F.

Virol J. 2012 Nov 22;9:283. doi: 10.1186/1743-422X-9-283.

2.

Evidence of a humoral response to a novel protein WARF4 embedded in the West Nile virus NS4B gene encoded by an alternative open reading frame.

Faggioni G, Ciammaruconi A, De Santis R, Pomponi A, Scicluna MT, Barbaro K, Masuelli L, Autorino G, Bei R, Lista F.

Int J Mol Med. 2009 Apr;23(4):509-12.

PMID:
19288027
3.

A glycosylated peptide in the West Nile virus envelope protein is immunogenic during equine infection.

Hobson-Peters J, Toye P, Sánchez MD, Bossart KN, Wang LF, Clark DC, Cheah WY, Hall RA.

J Gen Virol. 2008 Dec;89(Pt 12):3063-72. doi: 10.1099/vir.0.2008/003731-0.

PMID:
19008394
4.
5.

Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.

Chaintoutis SC, Diakakis N, Papanastassopoulou M, Banos G, Dovas CI.

Clin Vaccine Immunol. 2015 Sep;22(9):1040-9. doi: 10.1128/CVI.00302-15. Epub 2015 Jul 15.

6.

Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.

Siger L, Bowen RA, Karaca K, Murray MJ, Gordy PW, Loosmore SM, Audonnet JC, Nordgren RM, Minke JM.

Am J Vet Res. 2004 Nov;65(11):1459-62.

PMID:
15566080
7.

A recombinant fusion protein consisting of West Nile virus envelope domain III fused in-frame with equine CD40 ligand induces antiviral immune responses in horses.

Liu SA, Haque M, Stanfield B, Andrews FM, Roy AA, Kousoulas KG.

Vet Microbiol. 2017 Jan;198:51-58. doi: 10.1016/j.vetmic.2016.12.008. Epub 2016 Dec 8.

PMID:
28062007
8.

A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.

El Garch H, Minke JM, Rehder J, Richard S, Edlund Toulemonde C, Dinic S, Andreoni C, Audonnet JC, Nordgren R, Juillard V.

Vet Immunol Immunopathol. 2008 Jun 15;123(3-4):230-9. doi: 10.1016/j.vetimm.2008.02.002. Epub 2008 Feb 16.

PMID:
18372050
9.

Antibody response in horses following experimental infection with West Nile Virus lineages 1 and 2.

Castillo-Olivares J, Mansfield KL, Phipps LP, Johnson N, Tearle J, Fooks AR.

Transbound Emerg Dis. 2011 Jun;58(3):206-12. doi: 10.1111/j.1865-1682.2010.01197.x. Epub 2011 Jan 12.

PMID:
21223533
10.

West Nile virus: characterization and diagnostic applications of monoclonal antibodies.

Lelli D, Moreno A, Brocchi E, Sozzi E, Capucci L, Canelli E, Barbieri I, Zeller H, Cordioli P.

Virol J. 2012 Apr 13;9:81. doi: 10.1186/1743-422X-9-81.

11.

[Surveillance of West Nile fever in horses in the Czech Republic from 2011 to 2013].

Sedlák K, Zelená H, Křivda V, Šatrán P.

Epidemiol Mikrobiol Imunol. 2014 Nov;63(4):307-11. Czech.

PMID:
25523225
12.

Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).

Rosas CT, Tischer BK, Perkins GA, Wagner B, Goodman LB, Osterrieder N.

Virus Res. 2007 Apr;125(1):69-78. Epub 2007 Jan 22.

PMID:
17241683
13.

Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses.

Schepp-Berglind J, Luo M, Wang D, Wicker JA, Raja NU, Hoel BD, Holman DH, Barrett AD, Dong JY.

Clin Vaccine Immunol. 2007 Sep;14(9):1117-26. Epub 2007 Jul 18.

14.

Experimental infection of horses with West Nile virus.

Bunning ML, Bowen RA, Cropp CB, Sullivan KG, Davis BS, Komar N, Godsey MS, Baker D, Hettler DL, Holmes DA, Biggerstaff BJ, Mitchell CJ.

Emerg Infect Dis. 2002 Apr;8(4):380-6.

15.

West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.

Khatibzadeh SM, Gold CB, Keggan AE, Perkins GA, Glaser AL, Dubovi EJ, Wagner B.

Am J Vet Res. 2015 Jan;76(1):92-100. doi: 10.2460/ajvr.76.1.92.

PMID:
25535666
16.

Antibody responses induced by experimental West Nile virus infection with or without previous immunization with inactivated Japanese encephalitis vaccine in horses.

Shirafuji H, Kanehira K, Kamio T, Kubo M, Shibahara T, Konishi M, Murakami K, Nakamura Y, Yamanaka T, Kondo T, Matsumura T, Muranaka M, Katayama Y.

J Vet Med Sci. 2009 Jul;71(7):969-74.

17.

Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge.

Minke JM, Siger L, Karaca K, Austgen L, Gordy P, Bowen R, Renshaw RW, Loosmore S, Audonnet JC, Nordgren B.

Arch Virol Suppl. 2004;(18):221-30.

PMID:
15119777
18.

Epitope discovery in West Nile virus infection: Identification and immune recognition of viral epitopes.

McMurtrey CP, Lelic A, Piazza P, Chakrabarti AK, Yablonsky EJ, Wahl A, Bardet W, Eckerd A, Cook RL, Hess R, Buchli R, Loeb M, Rinaldo CR, Bramson J, Hildebrand WH.

Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2981-6. doi: 10.1073/pnas.0711874105. Epub 2008 Feb 25.

19.

Development of monoclonal antibodies to West Nile virus and their application in immunohistochemistry.

Hirota J, Shimizu S, Shibahara T, Isobe T, Yamada M, Tanimura N.

Clin Vaccine Immunol. 2012 Nov;19(11):1853-8. doi: 10.1128/CVI.00492-12. Epub 2012 Sep 19.

20.

Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.

Minke JM, Siger L, Cupillard L, Powers B, Bakonyi T, Boyum S, Nowotny N, Bowen R.

Vaccine. 2011 Jun 20;29(28):4608-12. doi: 10.1016/j.vaccine.2011.04.058. Epub 2011 May 5.

PMID:
21549780

Supplemental Content

Support Center